We then analyzed the positioning of disease-associated mutations (XP, CS, and combined XP/CS phenotypes) within the XPD protein network for each macrostate to clarify the consequences of XPD functional impairment. This evidence concerns the gene ERCC2 and xeroderma pigmentosum.